52 related articles for article (PubMed ID: 8659372)
1. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors.
Tien RD; Lai PH; Smith JS; Lazeyras F
AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372
[TBL] [Abstract][Full Text] [Related]
2. Constrained Source Space MR Spectroscopy: Multiple Voxels, No Gradient Readout.
Landheer K; Sahgal A; Das S; Graham SJ
AJNR Am J Neuroradiol; 2015 Aug; 36(8):1436-43. PubMed ID: 26089315
[TBL] [Abstract][Full Text] [Related]
3. Advanced Magnetic Resonance Imaging in Pediatric Glioblastomas.
Gonçalves FG; Viaene AN; Vossough A
Front Neurol; 2021; 12():733323. PubMed ID: 34858308
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Magnetic Resonance Spectroscopy as a Tool for Monitoring Therapeutic Response of Whole Brain Radiotherapy in a Mouse Model for Breast-to-Brain Metastasis.
Chae WH; Niesel K; Schulz M; Klemm F; Joyce JA; Prümmer M; Brill B; Bergs J; Rödel F; Pilatus U; Sevenich L
Front Oncol; 2019; 9():1324. PubMed ID: 31828043
[TBL] [Abstract][Full Text] [Related]
5. Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells.
Mesti T; Bouchemal N; Banissi C; Triba MN; Marbeuf-Gueye C; Cemazar M; Moyec LL; Carpentier AF; Savarin P; Ocvirk J
Radiol Oncol; 2018 Nov; 52(4):392-398. PubMed ID: 30511933
[TBL] [Abstract][Full Text] [Related]
6. The Significance of Lactate and Lipid Peaks for Predicting Primary Neuroepithelial Tumor Grade with Proton MR Spectroscopy.
Nakamura H; Doi M; Suzuki T; Yoshida Y; Hoshikawa M; Uchida M; Tanaka Y; Takagi M; Nakajima Y
Magn Reson Med Sci; 2018 Jul; 17(3):238-243. PubMed ID: 28819084
[TBL] [Abstract][Full Text] [Related]
7. Modern brain tumor imaging.
Mabray MC; Barajas RF; Cha S
Brain Tumor Res Treat; 2015 Apr; 3(1):8-23. PubMed ID: 25977902
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vertebral bone marrow fat assessed by 1H MRS and inphase and out-of-phase MRI among family members.
Ojanen X; Borra RJ; Havu M; Cheng SM; Parkkola R; Nuutila P; Alen M; Cheng S
Osteoporos Int; 2014 Feb; 25(2):653-62. PubMed ID: 23943163
[TBL] [Abstract][Full Text] [Related]
9. Macromolecule content influences proton diffusibility in gliomas.
Goebell E; Fiehler J; Siemonsen S; Vaeterlein O; Heese O; Hagel C; Ding XQ; Buhk JH; Groth M; Kucinski T
Eur Radiol; 2011 Dec; 21(12):2626-32. PubMed ID: 21761279
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.
Yamasaki F; Kurisu K; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Saito T; Hanaya R; Sugiyama K
Neuro Oncol; 2011 Jul; 13(7):791-801. PubMed ID: 21653595
[TBL] [Abstract][Full Text] [Related]
11. Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo.
Li X; Vigneron DB; Cha S; Graves EE; Crawford F; Chang SM; Nelson SJ
AJNR Am J Neuroradiol; 2005 Apr; 26(4):760-9. PubMed ID: 15814918
[TBL] [Abstract][Full Text] [Related]
12. The nonspecific nature of proton spectroscopy in brain masses in children: a series of demyelinating lesions.
Pandya HG; Wilkinson ID; Agarwal SK; Griffiths PD
Neuroradiology; 2005 Dec; 47(12):955-9. PubMed ID: 15776226
[TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance spectroscopy of brain tumours].
Harting I; Jost G; Hacke N; Hartmann M
Nervenarzt; 2005 Apr; 76(4):403-17. PubMed ID: 15349736
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy.
Chang YW; Yoon HK; Shin HJ; Roh HG; Cho JM
Pediatr Radiol; 2003 Dec; 33(12):836-42. PubMed ID: 14564423
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.
Tzika AA; Zarifi MK; Goumnerova L; Astrakas LG; Zurakowski D; Young-Poussaint T; Anthony DC; Scott RM; Black PM
AJNR Am J Neuroradiol; 2002 Feb; 23(2):322-33. PubMed ID: 11847064
[TBL] [Abstract][Full Text] [Related]
16. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.
Schlemmer HP; Bachert P; Herfarth KK; Zuna I; Debus J; van Kaick G
AJNR Am J Neuroradiol; 2001 Aug; 22(7):1316-24. PubMed ID: 11498420
[TBL] [Abstract][Full Text] [Related]
17. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.
Dowling C; Bollen AW; Noworolski SM; McDermott MW; Barbaro NM; Day MR; Henry RG; Chang SM; Dillon WP; Nelson SJ; Vigneron DB
AJNR Am J Neuroradiol; 2001 Apr; 22(4):604-12. PubMed ID: 11290466
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of intramedullary spinal cord tumors.
Lowe GM
J Neurooncol; 2000 May; 47(3):195-210. PubMed ID: 11016736
[TBL] [Abstract][Full Text] [Related]
19. Serial MRI and MRS studies with unusual findings in Rasmussen's encephalitis.
Türkdogan-Sözüer D; Ozek MM; Sav A; Dinçer A; Pamir MN
Eur Radiol; 2000; 10(6):962-6. PubMed ID: 10879711
[TBL] [Abstract][Full Text] [Related]
20. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.
Shimizu H; Kumabe T; Shirane R; Yoshimoto T
AJNR Am J Neuroradiol; 2000 Apr; 21(4):659-65. PubMed ID: 10782774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
